U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07841353) titled 'Impact of Trikafta on P2X7R and Clinical Outcomes in Cystic Fibrosis' on Sept. 08.
Brief Summary: The aim of this study is to assess the response of the ETI on P2X7R level as inflammatory marker and clinical outcomes in patients with cystic fibrosis.
Study Start Date: July 25, 2025
Study Type: OBSERVATIONAL
Condition:
Cystic Fibrosis (CF)
Recruitment Status: COMPLETED
Sponsor: Ain Shams University
Published by HT Digital Content Services with permission from Health Daily Digest....